Prophylactic NSAID Administration

PreclinicalSmall molecule

Prophylactic NSAID Administration is one of 35 small molecule programs targeting Abortion. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AbortionActive, not recruiting

AbortionPreclinical

Active, not recruiting

Competition

Competitive Landscape

97 competitors in Abortion

#DrugCompanyPhaseTrials

Cytotec

Pfizer

Approved

34 2

Prometrium

Ferring

Approved

2 3

Versed

CConrado Roberto Hoffmann Filho

Approved

1 4

Advil

KKenvue Brands

Phase 3

5 5

Oxycontin

PProtega

Phase 3

1 6

Dostinex

Pfizer

Phase 2

2 7

Enoxaparine

Sanofi

Phase 3

1 8

Dextromethorphan Hydrobromide

Boehringer Ingelheim

Phase 3

1 9

Spravato

WWim Janssens

Phase 2

1 10

Anerem

AAcacia Pharma Ltd

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Abortion1 trial

Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22 Weeks at Hung Vuong Hospital

Recruiting·LLe Thi Kieu Trang·N/A·NCT06696573·180 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Prophylactic NSAID Administration. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prophylactic NSAID Administration compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prophylactic NSAID Administration. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Le Thi Kieu Trang company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: LLe Thi Kieu Trang

Prophylactic NSAID Administration

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Abortion1 trial

References

Drug Info

Quick Facts

Related News